Drugs / Nanochitosan
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06782087 | Oct 2025 overdue | tooth disorder | Misr University for Science and Technology | Enrolling by invitation | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT07694024 | Jan → May 2016 | denture stomatitis, oral candidiasis | Kerman University of Medical Sciences | Completed | No outcome recorded |
| Phase 2 | NCT07793331 | Jan → Dec 2016 | denture stomatitis, oral candidiasis | Kerman University of Medical Sciences | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07571837 | Feb 2026 → Jan 2027 expected | periapical periodontitis | Al-Azhar University | Recruiting | No outcome recorded |
| — | NCT06253247 | Apr → Jun 2024 | — | Cairo University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nanochitosan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07793331 ↗ |
| Modality | Other / unclassified | “nanochitosan particles prepared by the ionic gelation method” NCT07793331 ↗ |
| Route | Other | “NanoChitosan impregnated Calcium Hydroxide used as an intracanal medication fro 7 days” NCT06253247 ↗ |